Webinar On The FDA Drug Approval Process

15 January 2015, Mississauga, Canada


Introduction
This web seminar provides an overview of the entire FDA Drug Approval Process. This seminar will cover FDA requirements from discovery.

We will begin by developing a molecule, testing it, going through the IND process, clinical testing and finally the NDA process. We will also discuss IND/NDA submission preparation, in-vitro studies, nonclinical studies and human clinical trials. Also discussed will be the underlying scientific and regulatory principles involved in the entire Drug Development Process. This web seminar will also provide a foundation of knowledge for those who require an understanding of the entire FDA Drug Approval Process.

Areas Covered in the Session :
Understand the FDA drug research requirements
Learn about IND process
Learn about Clinical testing requirements
Learn about NDA process
Learn about in-vitro and nonclinical testing

Who Will Benefit:
Regulatory Affairs Personnel
Quality Personnel
Clinical Personnel
Research Personnel
Manufacturing Personnel
Drug Discovery Personnel
Legal Personnel
Personnel who require a general understanding of the FDA Drug Approval Process

Price Tags:
Live
Single Live : For One Participant
$ 249
Corporate Live : For Max. 10 Participants
$ 899
Recording
Single REC : For One Participant - Unlimited Access for 6 Months
$ 299

For more information and enquiries contact us at
Compliance Trainings
5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada
Customer Support : #416-915-4458
Email : support@compliancetrainings.com
Speakers
Venue
Online

Compliance Trainings, Online, 5939 Candlebrook Court, Ontario, Mississauga, L5V 2V5, Canada

Organised by
Compliance Trainings is the global organization for regulatory affairs professionals for those who have an interest in regulatory affairs in Food, drugs, Biologics, Medical, Healthcare, HR, IT sectors.
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*